We are live on ! Find out more
GOVXW

GeoVax Labs Warrants

Delisted

GOVXW was delisted on the 26th of September, 2025.

3 hedge funds and large institutions have $12.8K invested in GeoVax Labs Warrants in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 33 (0)

56% less capital invested

Capital invested by funds: $29K → $12.8K (-$16.2K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
3
Holders Change
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
2
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
CH
1
CVI Holdings
Delaware
$10.2K
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$2.64K -$2.58K -12,117 -41%
UBS Group
3
UBS Group
Switzerland
$8 -$1.58K -7,436 -99%

GOVXW Hedge Fund Activity: Q4 2022 in Review

3 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in GeoVax Labs Warrants (GOVXW) for Q4 2022, worth a combined $12.8K — down 56% from $29K a quarter earlier.

Fund positioning in GOVXW was balanced in Q4 2022: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 2 trimmed.

The largest seller was Susquehanna International Group, cutting an estimated $2.58K.

  • 3 institutional investors held GeoVax Labs Warrants (GOVXW) as of Q4 2022, unchanged from Q3 2022.
  • Funds reported $12.8K of GeoVax Labs Warrants stock for Q4 2022, down 56% quarter-over-quarter.
  • 0 funds opened new GeoVax Labs Warrants positions in Q4 2022 and 0 closed out.
  • The largest GeoVax Labs Warrants seller in Q4 2022 was Susquehanna International Group, an estimated $2.58K sold.

Based on aggregated 13F filings for Q4 2022.